Table 5

- Correlation between epilepsy medications polypharmacy and adherence status.

Variables	Total		Adherence		Nonadherence		P-value
Variables	Number	%≥	Number	(%)	Number	(%)	P-value
Polypharmacy
yes polypharmacy	60	29.27	49	(29.34)	11	(28.95)	0.962
No polypharmacy	145	70.73	118	(70.66)	27	(71.05)	0.962
Levetiracetam
Yes	115	55.56	90	(53.25)	25	(65.79)	0.160
No	92	44.44	79	(46.75)	13	(34.21)	0.160
Valproic Acid
Yes	21	10.14	17	(10.06)	4	(10.53)	0.931
No	186	89.86	152	(89.94)	34	(89.47)	0.931
Carbamazepine
Yes	58	28.02	46	(27.22)	12	(31.58)	0.589
No	149	71.98	123	(72.78)	26	(68.42)	0.589
Lamotrigine
Yes	24	11.59	23	(13.61)	1	(2.63)	0.040*
No	183	88.41	146	(86.39)	37	(97.37)	0.040*
Phenytoin
Yes	4	1.93	4	(2.37)	0	(0.00)	0.441
No	203	98.07	165	(97.63)	38	(100.00)	0.441
Topiramate
Yes	5	2.42	3	(1.78)	2	(5.26)	0.228
No	202	97.58	166	(98.22)	36	(94.74)	0.228
Clonazepam
Yes	1	0.48	1	(0.59)	0	(0.00)	0.816
No	206	99.52	168	(99.41)	38	(100.00)	0.816
Lacosamide
Yes	5	2.42	5	(2.96)	0	(0.00)	0.359
No	202	97.58	164	(97.04)	38	(100.00)	0.359
Phenobarbital
Yes	1	0.48	1	(0.59)	0	(0.00)	0.816
No	206	99.52	168	(99.41)	38	(100.00)	0.816

Significant p-value